Tide Ocean turns ocean plastic waste into watches
Basel-based start-up Tide Ocean turns ocean plastic waste into new products such as watches. It has now won a German design and technology award for its contribution to the circular economy.
Tide Ocean turns ocean plastic waste into high-quality plastic granules and thread, yarn or fabric (img: courtesy of Tide Ocean)
Up to now, ocean plastic waste has been difficult to recycle due to damage caused by UV rays and salt water. Basel-based start-up Tide Ocean has now developed a method together with scientists from the University of Applied Sciences in Rapperswil that allows it to turn plastic collected from the ocean, coastlines and uncontrolled landfills into high-quality plastic granules, which can be then used to recreate new hard plastic products such as watches, furniture or electronic devices. Tide Ocean can also turn the ocean plastic waste into thread, yarn or fabric for use in clothing, watch straps or bags.
Tide Ocean has now won the 17th MATERIALICA Design and Technology Award for its contribution to the circular economy. Company founder Thomas Shori accepted the award at the electric mobility trade fair eMove 360 in Munich.
“We are tremendously pleased that our innovative solution has been recognized by experts and scientists with this well-established award,” Schori said. “We believe that even little solutions can tackle big problems if we are to improve the world.”
In its first year, Tide Ocean has processed more than 30 tonnes of ocean material.
Share this article
You might also be interested in
The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...Read More
The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...Read More
The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it. However, Switzerland is among the...Read More
The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...Read More
The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...Read More